nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—FMO3—Nicotine Metabolism—CYP2A6—hepatitis B	0.0276	0.144	CbGpPWpGaD
Almotriptan—Myopathy—Adefovir Dipivoxil—hepatitis B	0.0231	0.0305	CcSEcCtD
Almotriptan—Myopathy—Telbivudine—hepatitis B	0.0194	0.0257	CcSEcCtD
Almotriptan—Neck pain—Telbivudine—hepatitis B	0.0138	0.0183	CcSEcCtD
Almotriptan—Abdominal cramps—Lamivudine—hepatitis B	0.0114	0.0151	CcSEcCtD
Almotriptan—Abdominal pain upper—Entecavir—hepatitis B	0.011	0.0146	CcSEcCtD
Almotriptan—Myopathy—Lamivudine—hepatitis B	0.011	0.0145	CcSEcCtD
Almotriptan—FMO3—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0101	0.053	CbGpPWpGaD
Almotriptan—Pain in extremity—Telbivudine—hepatitis B	0.0099	0.0131	CcSEcCtD
Almotriptan—Hyperglycaemia—Entecavir—hepatitis B	0.00939	0.0124	CcSEcCtD
Almotriptan—Abdominal pain upper—Telbivudine—hepatitis B	0.00904	0.012	CcSEcCtD
Almotriptan—Gastritis—Telbivudine—hepatitis B	0.00876	0.0116	CcSEcCtD
Almotriptan—Vasodilation procedure—Lamivudine—hepatitis B	0.00875	0.0116	CcSEcCtD
Almotriptan—Vasodilation—Lamivudine—hepatitis B	0.00875	0.0116	CcSEcCtD
Almotriptan—Muscular weakness—Telbivudine—hepatitis B	0.00873	0.0115	CcSEcCtD
Almotriptan—Bone disorder—Lamivudine—hepatitis B	0.00851	0.0113	CcSEcCtD
Almotriptan—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0085	0.0112	CcSEcCtD
Almotriptan—Abdominal discomfort—Telbivudine—hepatitis B	0.0082	0.0108	CcSEcCtD
Almotriptan—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00812	0.0107	CcSEcCtD
Almotriptan—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00807	0.0107	CcSEcCtD
Almotriptan—Immune system disorder—Entecavir—hepatitis B	0.00753	0.00996	CcSEcCtD
Almotriptan—Neuropathy peripheral—Telbivudine—hepatitis B	0.00748	0.00989	CcSEcCtD
Almotriptan—Mental disorder—Entecavir—hepatitis B	0.0073	0.00966	CcSEcCtD
Almotriptan—Neuropathy—Lamivudine—hepatitis B	0.00721	0.00954	CcSEcCtD
Almotriptan—Back pain—Adefovir Dipivoxil—hepatitis B	0.00685	0.00906	CcSEcCtD
Almotriptan—Hypoaesthesia—Telbivudine—hepatitis B	0.00681	0.00901	CcSEcCtD
Almotriptan—Pharyngitis—Telbivudine—hepatitis B	0.0068	0.00899	CcSEcCtD
Almotriptan—Gastroenteritis—Lamivudine—hepatitis B	0.00629	0.00833	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00613	0.00812	CcSEcCtD
Almotriptan—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00603	0.00797	CcSEcCtD
Almotriptan—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00603	0.00797	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00599	0.00792	CcSEcCtD
Almotriptan—Anaphylactic shock—Entecavir—hepatitis B	0.00592	0.00783	CcSEcCtD
Almotriptan—Thirst—Lamivudine—hepatitis B	0.00586	0.00775	CcSEcCtD
Almotriptan—Dysgeusia—Telbivudine—hepatitis B	0.00584	0.00772	CcSEcCtD
Almotriptan—Nervous system disorder—Entecavir—hepatitis B	0.00581	0.00768	CcSEcCtD
Almotriptan—Back pain—Telbivudine—hepatitis B	0.00577	0.00763	CcSEcCtD
Almotriptan—Skin disorder—Entecavir—hepatitis B	0.00575	0.00761	CcSEcCtD
Almotriptan—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00567	0.0075	CcSEcCtD
Almotriptan—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00561	0.00742	CcSEcCtD
Almotriptan—Ill-defined disorder—Telbivudine—hepatitis B	0.00553	0.00732	CcSEcCtD
Almotriptan—Malaise—Telbivudine—hepatitis B	0.00538	0.00711	CcSEcCtD
Almotriptan—Insomnia—Entecavir—hepatitis B	0.00536	0.00709	CcSEcCtD
Almotriptan—Somnolence—Entecavir—hepatitis B	0.00526	0.00696	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00526	0.00696	CcSEcCtD
Almotriptan—Dyspepsia—Entecavir—hepatitis B	0.00521	0.0069	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Entecavir—hepatitis B	0.00511	0.00676	CcSEcCtD
Almotriptan—Fatigue—Entecavir—hepatitis B	0.00511	0.00675	CcSEcCtD
Almotriptan—Abdominal pain upper—Lamivudine—hepatitis B	0.00509	0.00674	CcSEcCtD
Almotriptan—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00509	0.00673	CcSEcCtD
Almotriptan—Chest pain—Telbivudine—hepatitis B	0.00507	0.00671	CcSEcCtD
Almotriptan—Myalgia—Telbivudine—hepatitis B	0.00507	0.00671	CcSEcCtD
Almotriptan—Arthralgia—Telbivudine—hepatitis B	0.00507	0.00671	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00504	0.00667	CcSEcCtD
Almotriptan—Discomfort—Telbivudine—hepatitis B	0.00501	0.00663	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00499	0.0066	CcSEcCtD
Almotriptan—CYP2E1—CYP2E1 reactions—CYP2A6—hepatitis B	0.00498	0.026	CbGpPWpGaD
Almotriptan—Muscular weakness—Lamivudine—hepatitis B	0.00492	0.00651	CcSEcCtD
Almotriptan—CYP2C19—blood plasma—hepatitis B	0.00488	0.101	CbGeAlD
Almotriptan—Gastrointestinal pain—Entecavir—hepatitis B	0.00484	0.00641	CcSEcCtD
Almotriptan—Eletriptan—CYP2A6—hepatitis B	0.00482	1	CrCbGaD
Almotriptan—MAOA—blood plasma—hepatitis B	0.00478	0.0992	CbGeAlD
Almotriptan—Nervous system disorder—Telbivudine—hepatitis B	0.00477	0.00631	CcSEcCtD
Almotriptan—Skin disorder—Telbivudine—hepatitis B	0.00473	0.00625	CcSEcCtD
Almotriptan—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00472	0.00625	CcSEcCtD
Almotriptan—Sweating increased—Lamivudine—hepatitis B	0.0047	0.00621	CcSEcCtD
Almotriptan—Body temperature increased—Entecavir—hepatitis B	0.00468	0.00619	CcSEcCtD
Almotriptan—Abdominal pain—Entecavir—hepatitis B	0.00468	0.00619	CcSEcCtD
Almotriptan—Bronchitis—Lamivudine—hepatitis B	0.00464	0.00613	CcSEcCtD
Almotriptan—Abdominal discomfort—Lamivudine—hepatitis B	0.00462	0.00611	CcSEcCtD
Almotriptan—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00457	0.00604	CcSEcCtD
Almotriptan—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00457	0.00604	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00443	0.00586	CcSEcCtD
Almotriptan—Insomnia—Telbivudine—hepatitis B	0.0044	0.00582	CcSEcCtD
Almotriptan—Paraesthesia—Telbivudine—hepatitis B	0.00437	0.00578	CcSEcCtD
Almotriptan—Hyperglycaemia—Lamivudine—hepatitis B	0.00435	0.00575	CcSEcCtD
Almotriptan—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.0043	0.0225	CbGpPWpGaD
Almotriptan—Dyspepsia—Telbivudine—hepatitis B	0.00428	0.00567	CcSEcCtD
Almotriptan—CYP2C8—blood plasma—hepatitis B	0.00426	0.0885	CbGeAlD
Almotriptan—Asthenia—Entecavir—hepatitis B	0.00425	0.00562	CcSEcCtD
Almotriptan—Neuropathy peripheral—Lamivudine—hepatitis B	0.00421	0.00557	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0042	0.00556	CcSEcCtD
Almotriptan—Fatigue—Telbivudine—hepatitis B	0.00419	0.00555	CcSEcCtD
Almotriptan—Pain—Telbivudine—hepatitis B	0.00416	0.0055	CcSEcCtD
Almotriptan—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00415	0.00548	CcSEcCtD
Almotriptan—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00409	0.00541	CcSEcCtD
Almotriptan—Epistaxis—Lamivudine—hepatitis B	0.00405	0.00536	CcSEcCtD
Almotriptan—Diarrhoea—Entecavir—hepatitis B	0.00405	0.00536	CcSEcCtD
Almotriptan—Sinusitis—Lamivudine—hepatitis B	0.00403	0.00534	CcSEcCtD
Almotriptan—CYP1A2—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.00402	0.021	CbGpPWpGaD
Almotriptan—Feeling abnormal—Telbivudine—hepatitis B	0.00401	0.0053	CcSEcCtD
Almotriptan—CYP1A2—blood plasma—hepatitis B	0.00399	0.0828	CbGeAlD
Almotriptan—Gastrointestinal pain—Telbivudine—hepatitis B	0.00398	0.00526	CcSEcCtD
Almotriptan—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00395	0.00523	CcSEcCtD
Almotriptan—Dizziness—Entecavir—hepatitis B	0.00392	0.00518	CcSEcCtD
Almotriptan—Rhinitis—Lamivudine—hepatitis B	0.00387	0.00512	CcSEcCtD
Almotriptan—Abdominal pain—Telbivudine—hepatitis B	0.00385	0.00509	CcSEcCtD
Almotriptan—Body temperature increased—Telbivudine—hepatitis B	0.00385	0.00509	CcSEcCtD
Almotriptan—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00384	0.0201	CbGpPWpGaD
Almotriptan—Hypoaesthesia—Lamivudine—hepatitis B	0.00384	0.00508	CcSEcCtD
Almotriptan—Pharyngitis—Lamivudine—hepatitis B	0.00383	0.00507	CcSEcCtD
Almotriptan—Vomiting—Entecavir—hepatitis B	0.00377	0.00498	CcSEcCtD
Almotriptan—Rash—Entecavir—hepatitis B	0.00373	0.00494	CcSEcCtD
Almotriptan—Dermatitis—Entecavir—hepatitis B	0.00373	0.00494	CcSEcCtD
Almotriptan—Headache—Entecavir—hepatitis B	0.00371	0.00491	CcSEcCtD
Almotriptan—CYP2E1—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00369	0.0193	CbGpPWpGaD
Almotriptan—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00367	0.00486	CcSEcCtD
Almotriptan—Rash—Adefovir Dipivoxil—hepatitis B	0.00364	0.00482	CcSEcCtD
Almotriptan—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00364	0.00481	CcSEcCtD
Almotriptan—Headache—Adefovir Dipivoxil—hepatitis B	0.00362	0.00479	CcSEcCtD
Almotriptan—CYP2E1—blood plasma—hepatitis B	0.00359	0.0745	CbGeAlD
Almotriptan—FMO3—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00354	0.0185	CbGpPWpGaD
Almotriptan—CYP2D6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00353	0.0185	CbGpPWpGaD
Almotriptan—Nausea—Entecavir—hepatitis B	0.00352	0.00465	CcSEcCtD
Almotriptan—Asthenia—Telbivudine—hepatitis B	0.00349	0.00462	CcSEcCtD
Almotriptan—Immune system disorder—Lamivudine—hepatitis B	0.00349	0.00461	CcSEcCtD
Almotriptan—Chills—Lamivudine—hepatitis B	0.00346	0.00458	CcSEcCtD
Almotriptan—Pruritus—Telbivudine—hepatitis B	0.00344	0.00455	CcSEcCtD
Almotriptan—Nausea—Adefovir Dipivoxil—hepatitis B	0.00343	0.00454	CcSEcCtD
Almotriptan—Erythema—Lamivudine—hepatitis B	0.00336	0.00444	CcSEcCtD
Almotriptan—Diarrhoea—Telbivudine—hepatitis B	0.00333	0.0044	CcSEcCtD
Almotriptan—Tension—Lamivudine—hepatitis B	0.0033	0.00436	CcSEcCtD
Almotriptan—Dysgeusia—Lamivudine—hepatitis B	0.00329	0.00435	CcSEcCtD
Almotriptan—Nervousness—Lamivudine—hepatitis B	0.00326	0.00432	CcSEcCtD
Almotriptan—Back pain—Lamivudine—hepatitis B	0.00325	0.0043	CcSEcCtD
Almotriptan—Dizziness—Telbivudine—hepatitis B	0.00322	0.00426	CcSEcCtD
Almotriptan—FMO3—Metapathway biotransformation—AKR1B1—hepatitis B	0.0032	0.0167	CbGpPWpGaD
Almotriptan—CYP1A2—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00319	0.0167	CbGpPWpGaD
Almotriptan—FMO3—liver—hepatitis B	0.00317	0.0657	CbGeAlD
Almotriptan—Tremor—Lamivudine—hepatitis B	0.00315	0.00416	CcSEcCtD
Almotriptan—Ill-defined disorder—Lamivudine—hepatitis B	0.00312	0.00412	CcSEcCtD
Almotriptan—FMO3—Biological oxidations—GGT2—hepatitis B	0.00311	0.0163	CbGpPWpGaD
Almotriptan—Vomiting—Telbivudine—hepatitis B	0.00309	0.00409	CcSEcCtD
Almotriptan—CYP2E1—Xenobiotics—CYP2A6—hepatitis B	0.00309	0.0161	CbGpPWpGaD
Almotriptan—Angioedema—Lamivudine—hepatitis B	0.00307	0.00406	CcSEcCtD
Almotriptan—Rash—Telbivudine—hepatitis B	0.00307	0.00406	CcSEcCtD
Almotriptan—Dermatitis—Telbivudine—hepatitis B	0.00306	0.00405	CcSEcCtD
Almotriptan—Headache—Telbivudine—hepatitis B	0.00305	0.00403	CcSEcCtD
Almotriptan—Malaise—Lamivudine—hepatitis B	0.00303	0.00401	CcSEcCtD
Almotriptan—Vertigo—Lamivudine—hepatitis B	0.00302	0.00399	CcSEcCtD
Almotriptan—Syncope—Lamivudine—hepatitis B	0.00301	0.00399	CcSEcCtD
Almotriptan—CYP2E1—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00297	0.0155	CbGpPWpGaD
Almotriptan—Loss of consciousness—Lamivudine—hepatitis B	0.00295	0.00391	CcSEcCtD
Almotriptan—Convulsion—Lamivudine—hepatitis B	0.00291	0.00385	CcSEcCtD
Almotriptan—Nausea—Telbivudine—hepatitis B	0.00289	0.00382	CcSEcCtD
Almotriptan—CYP3A4—blood plasma—hepatitis B	0.00289	0.0599	CbGeAlD
Almotriptan—Chest pain—Lamivudine—hepatitis B	0.00286	0.00378	CcSEcCtD
Almotriptan—Myalgia—Lamivudine—hepatitis B	0.00286	0.00378	CcSEcCtD
Almotriptan—Arthralgia—Lamivudine—hepatitis B	0.00286	0.00378	CcSEcCtD
Almotriptan—Anxiety—Lamivudine—hepatitis B	0.00285	0.00377	CcSEcCtD
Almotriptan—CYP2D6—blood plasma—hepatitis B	0.00284	0.059	CbGeAlD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00284	0.00376	CcSEcCtD
Almotriptan—Discomfort—Lamivudine—hepatitis B	0.00283	0.00374	CcSEcCtD
Almotriptan—Dry mouth—Lamivudine—hepatitis B	0.0028	0.0037	CcSEcCtD
Almotriptan—Confusional state—Lamivudine—hepatitis B	0.00276	0.00366	CcSEcCtD
Almotriptan—Anaphylactic shock—Lamivudine—hepatitis B	0.00274	0.00363	CcSEcCtD
Almotriptan—Shock—Lamivudine—hepatitis B	0.0027	0.00357	CcSEcCtD
Almotriptan—Nervous system disorder—Lamivudine—hepatitis B	0.00269	0.00356	CcSEcCtD
Almotriptan—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.00267	0.014	CbGpPWpGaD
Almotriptan—Skin disorder—Lamivudine—hepatitis B	0.00266	0.00352	CcSEcCtD
Almotriptan—Hyperhidrosis—Lamivudine—hepatitis B	0.00265	0.00351	CcSEcCtD
Almotriptan—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00262	0.0137	CbGpPWpGaD
Almotriptan—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00257	0.0134	CbGpPWpGaD
Almotriptan—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.0025	0.0033	CcSEcCtD
Almotriptan—Insomnia—Lamivudine—hepatitis B	0.00248	0.00328	CcSEcCtD
Almotriptan—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00246	0.0129	CbGpPWpGaD
Almotriptan—Paraesthesia—Lamivudine—hepatitis B	0.00246	0.00326	CcSEcCtD
Almotriptan—Dyspnoea—Lamivudine—hepatitis B	0.00244	0.00323	CcSEcCtD
Almotriptan—Somnolence—Lamivudine—hepatitis B	0.00244	0.00322	CcSEcCtD
Almotriptan—Dyspepsia—Lamivudine—hepatitis B	0.00241	0.00319	CcSEcCtD
Almotriptan—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00238	0.0125	CbGpPWpGaD
Almotriptan—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00237	0.00313	CcSEcCtD
Almotriptan—Fatigue—Lamivudine—hepatitis B	0.00236	0.00313	CcSEcCtD
Almotriptan—Pain—Lamivudine—hepatitis B	0.00234	0.0031	CcSEcCtD
Almotriptan—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00229	0.012	CbGpPWpGaD
Almotriptan—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00229	0.012	CbGpPWpGaD
Almotriptan—Feeling abnormal—Lamivudine—hepatitis B	0.00226	0.00299	CcSEcCtD
Almotriptan—Gastrointestinal pain—Lamivudine—hepatitis B	0.00224	0.00297	CcSEcCtD
Almotriptan—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00222	0.0116	CbGpPWpGaD
Almotriptan—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.00219	0.0115	CbGpPWpGaD
Almotriptan—Abdominal pain—Lamivudine—hepatitis B	0.00217	0.00287	CcSEcCtD
Almotriptan—Body temperature increased—Lamivudine—hepatitis B	0.00217	0.00287	CcSEcCtD
Almotriptan—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00211	0.011	CbGpPWpGaD
Almotriptan—Hypersensitivity—Lamivudine—hepatitis B	0.00202	0.00267	CcSEcCtD
Almotriptan—Asthenia—Lamivudine—hepatitis B	0.00197	0.0026	CcSEcCtD
Almotriptan—Pruritus—Lamivudine—hepatitis B	0.00194	0.00257	CcSEcCtD
Almotriptan—FMO3—Biological oxidations—CYP2A6—hepatitis B	0.00188	0.00985	CbGpPWpGaD
Almotriptan—Diarrhoea—Lamivudine—hepatitis B	0.00188	0.00248	CcSEcCtD
Almotriptan—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.00186	0.00971	CbGpPWpGaD
Almotriptan—Dizziness—Lamivudine—hepatitis B	0.00181	0.0024	CcSEcCtD
Almotriptan—CYP2C19—blood—hepatitis B	0.00179	0.0371	CbGeAlD
Almotriptan—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00178	0.00933	CbGpPWpGaD
Almotriptan—MAOA—blood—hepatitis B	0.00175	0.0363	CbGeAlD
Almotriptan—Vomiting—Lamivudine—hepatitis B	0.00174	0.00231	CcSEcCtD
Almotriptan—Rash—Lamivudine—hepatitis B	0.00173	0.00229	CcSEcCtD
Almotriptan—Dermatitis—Lamivudine—hepatitis B	0.00173	0.00228	CcSEcCtD
Almotriptan—Headache—Lamivudine—hepatitis B	0.00172	0.00227	CcSEcCtD
Almotriptan—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00171	0.00895	CbGpPWpGaD
Almotriptan—MAOA—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00169	0.00886	CbGpPWpGaD
Almotriptan—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00163	0.00855	CbGpPWpGaD
Almotriptan—Nausea—Lamivudine—hepatitis B	0.00163	0.00215	CcSEcCtD
Almotriptan—CYP2C8—blood—hepatitis B	0.00156	0.0324	CbGeAlD
Almotriptan—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00151	0.00789	CbGpPWpGaD
Almotriptan—MAOA—Biological oxidations—GGT2—hepatitis B	0.00148	0.00777	CbGpPWpGaD
Almotriptan—FMO3—Biological oxidations—GGT1—hepatitis B	0.00147	0.00769	CbGpPWpGaD
Almotriptan—CYP1A2—blood—hepatitis B	0.00146	0.0303	CbGeAlD
Almotriptan—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00143	0.00749	CbGpPWpGaD
Almotriptan—CYP2C19—liver—hepatitis B	0.0014	0.029	CbGeAlD
Almotriptan—MAOA—Neuronal System—KCNH1—hepatitis B	0.00139	0.00726	CbGpPWpGaD
Almotriptan—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00138	0.0072	CbGpPWpGaD
Almotriptan—MAOA—liver—hepatitis B	0.00137	0.0284	CbGeAlD
Almotriptan—CYP2E1—blood—hepatitis B	0.00131	0.0273	CbGeAlD
Almotriptan—FMO3—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00131	0.00686	CbGpPWpGaD
Almotriptan—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00128	0.0067	CbGpPWpGaD
Almotriptan—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00126	0.00662	CbGpPWpGaD
Almotriptan—CYP2C8—liver—hepatitis B	0.00122	0.0253	CbGeAlD
Almotriptan—MAOA—Melatonin metabolism and effects—NFKB1—hepatitis B	0.00118	0.00616	CbGpPWpGaD
Almotriptan—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00116	0.00609	CbGpPWpGaD
Almotriptan—MAOA—Oxidative Stress—NFKB1—hepatitis B	0.00115	0.006	CbGpPWpGaD
Almotriptan—CYP1A2—liver—hepatitis B	0.00114	0.0237	CbGeAlD
Almotriptan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00111	0.00579	CbGpPWpGaD
Almotriptan—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00109	0.00572	CbGpPWpGaD
Almotriptan—CYP3A4—blood—hepatitis B	0.00106	0.022	CbGeAlD
Almotriptan—CYP2D6—blood—hepatitis B	0.00104	0.0216	CbGeAlD
Almotriptan—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00104	0.00543	CbGpPWpGaD
Almotriptan—CYP2E1—liver—hepatitis B	0.00103	0.0213	CbGeAlD
Almotriptan—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.001	0.00523	CbGpPWpGaD
Almotriptan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000989	0.00517	CbGpPWpGaD
Almotriptan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000983	0.00514	CbGpPWpGaD
Almotriptan—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000976	0.0051	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000937	0.0049	CbGpPWpGaD
Almotriptan—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000936	0.0049	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—GGT2—hepatitis B	0.000911	0.00477	CbGpPWpGaD
Almotriptan—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000909	0.00476	CbGpPWpGaD
Almotriptan—MAOA—Biological oxidations—CYP2A6—hepatitis B	0.000899	0.00471	CbGpPWpGaD
Almotriptan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000898	0.0047	CbGpPWpGaD
Almotriptan—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000897	0.00469	CbGpPWpGaD
Almotriptan—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000893	0.00467	CbGpPWpGaD
Almotriptan—CYP3A4—liver—hepatitis B	0.000827	0.0172	CbGeAlD
Almotriptan—CYP2D6—liver—hepatitis B	0.000814	0.0169	CbGeAlD
Almotriptan—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.00081	0.00424	CbGpPWpGaD
Almotriptan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000801	0.00419	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000787	0.00412	CbGpPWpGaD
Almotriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00077	0.00403	CbGpPWpGaD
Almotriptan—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00076	0.00398	CbGpPWpGaD
Almotriptan—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000737	0.00386	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000723	0.00378	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000703	0.00368	CbGpPWpGaD
Almotriptan—MAOA—Biological oxidations—GGT1—hepatitis B	0.000702	0.00367	CbGpPWpGaD
Almotriptan—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000696	0.00364	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000665	0.00348	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000661	0.00346	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000646	0.00338	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000642	0.00336	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000627	0.00328	CbGpPWpGaD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000624	0.00327	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—CXCL10—hepatitis B	0.0006	0.00314	CbGpPWpGaD
Almotriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000595	0.00311	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—CXCL10—hepatitis B	0.000588	0.00307	CbGpPWpGaD
Almotriptan—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000587	0.00307	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000563	0.00295	CbGpPWpGaD
Almotriptan—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000558	0.00292	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKR1B1—hepatitis B	0.000554	0.0029	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—CYP2A6—hepatitis B	0.000552	0.00289	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000548	0.00286	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GGT2—hepatitis B	0.000531	0.00278	CbGpPWpGaD
Almotriptan—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000513	0.00268	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000499	0.00261	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000482	0.00252	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000477	0.0025	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000477	0.0025	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000467	0.00244	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—CCR5—hepatitis B	0.000465	0.00243	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—CCR5—hepatitis B	0.000456	0.00238	CbGpPWpGaD
Almotriptan—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000443	0.00232	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000435	0.00227	CbGpPWpGaD
Almotriptan—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000435	0.00227	CbGpPWpGaD
Almotriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000432	0.00226	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—GGT1—hepatitis B	0.000431	0.00225	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000426	0.00223	CbGpPWpGaD
Almotriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000423	0.00221	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000423	0.00221	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000403	0.00211	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000392	0.00205	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000372	0.00195	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.00037	0.00194	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CXCL10—hepatitis B	0.000363	0.0019	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000362	0.0019	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000361	0.00189	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CXCL10—hepatitis B	0.000356	0.00186	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000332	0.00174	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000332	0.00174	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP2A6—hepatitis B	0.000322	0.00168	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000321	0.00168	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000317	0.00166	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000316	0.00165	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000315	0.00165	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000311	0.00163	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000307	0.0016	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000306	0.0016	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000303	0.00158	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.0003	0.00157	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GOT2—hepatitis B	0.000291	0.00152	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CCR5—hepatitis B	0.000282	0.00147	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000281	0.00147	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SAG—hepatitis B	0.000279	0.00146	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RIT2—hepatitis B	0.000279	0.00146	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CCR5—hepatitis B	0.000276	0.00144	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RIT2—hepatitis B	0.000273	0.00143	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SAG—hepatitis B	0.000273	0.00143	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKR1B1—hepatitis B	0.000265	0.00139	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000259	0.00135	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000256	0.00134	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GGT2—hepatitis B	0.000254	0.00133	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GGT1—hepatitis B	0.000251	0.00131	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GOT1—hepatitis B	0.000251	0.00131	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00025	0.00131	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—F2—hepatitis B	0.000242	0.00126	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000239	0.00125	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—F2—hepatitis B	0.000237	0.00124	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000234	0.00122	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000234	0.00122	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000219	0.00115	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL10—hepatitis B	0.000205	0.00107	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL10—hepatitis B	0.000201	0.00105	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.0002	0.00105	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000192	0.00101	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL10—hepatitis B	0.000186	0.000975	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL10—hepatitis B	0.000183	0.000955	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKR1B1—hepatitis B	0.000162	0.00085	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CCR5—hepatitis B	0.000159	0.000833	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCR5—hepatitis B	0.000156	0.000816	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GGT2—hepatitis B	0.000156	0.000815	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP2A6—hepatitis B	0.000154	0.000805	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCR5—hepatitis B	0.000145	0.000756	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000143	0.000748	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCR5—hepatitis B	0.000142	0.000741	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1B1—hepatitis B	0.00014	0.000735	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GOT2—hepatitis B	0.000139	0.000728	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—F2—hepatitis B	0.000137	0.000715	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GGT2—hepatitis B	0.000135	0.000704	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—F2—hepatitis B	0.000134	0.0007	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ALB—hepatitis B	0.000134	0.000699	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000128	0.000668	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1B1—hepatitis B	0.000125	0.000656	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—F2—hepatitis B	0.000124	0.000649	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—F2—hepatitis B	0.000121	0.000636	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GGT2—hepatitis B	0.00012	0.000629	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GOT1—hepatitis B	0.00012	0.000628	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GGT1—hepatitis B	0.00012	0.000628	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1B1—hepatitis B	0.000115	0.000603	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GGT2—hepatitis B	0.000111	0.000578	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL10—hepatitis B	0.00011	0.000576	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL10—hepatitis B	0.000108	0.000564	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTEN—hepatitis B	0.000102	0.000533	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.94e-05	0.00052	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1B1—hepatitis B	9.77e-05	0.000511	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2A6—hepatitis B	9.44e-05	0.000494	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GGT2—hepatitis B	9.36e-05	0.00049	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—hepatitis B	9.2e-05	0.000481	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—hepatitis B	9.01e-05	0.000471	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR5—hepatitis B	8.54e-05	0.000447	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GOT2—hepatitis B	8.53e-05	0.000446	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR5—hepatitis B	8.36e-05	0.000438	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—hepatitis B	8.35e-05	0.000437	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—hepatitis B	8.18e-05	0.000428	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2A6—hepatitis B	8.16e-05	0.000427	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.61e-05	0.000398	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1B1—hepatitis B	7.54e-05	0.000394	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GOT2—hepatitis B	7.38e-05	0.000386	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GGT1—hepatitis B	7.37e-05	0.000385	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GOT1—hepatitis B	7.37e-05	0.000385	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—F2—hepatitis B	7.33e-05	0.000383	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2A6—hepatitis B	7.28e-05	0.000381	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GGT2—hepatitis B	7.23e-05	0.000378	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—F2—hepatitis B	7.18e-05	0.000375	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.79e-05	0.000355	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2A6—hepatitis B	6.7e-05	0.00035	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GOT2—hepatitis B	6.58e-05	0.000344	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—hepatitis B	6.39e-05	0.000334	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GOT1—hepatitis B	6.37e-05	0.000333	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GGT1—hepatitis B	6.37e-05	0.000333	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GOT2—hepatitis B	6.06e-05	0.000317	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.8e-05	0.000304	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GGT1—hepatitis B	5.68e-05	0.000297	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GOT1—hepatitis B	5.68e-05	0.000297	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2A6—hepatitis B	5.67e-05	0.000297	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.29e-05	0.000277	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GOT1—hepatitis B	5.23e-05	0.000273	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GGT1—hepatitis B	5.23e-05	0.000273	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.18e-05	0.000271	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GOT2—hepatitis B	5.13e-05	0.000268	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—hepatitis B	4.94e-05	0.000258	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—hepatitis B	4.91e-05	0.000257	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—hepatitis B	4.87e-05	0.000255	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—hepatitis B	4.83e-05	0.000253	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—hepatitis B	4.81e-05	0.000252	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—hepatitis B	4.76e-05	0.000249	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—hepatitis B	4.67e-05	0.000244	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—hepatitis B	4.65e-05	0.000243	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—hepatitis B	4.64e-05	0.000243	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NFKB1—hepatitis B	4.62e-05	0.000242	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—hepatitis B	4.56e-05	0.000238	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—hepatitis B	4.55e-05	0.000238	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NFKB1—hepatitis B	4.53e-05	0.000237	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GGT1—hepatitis B	4.43e-05	0.000232	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GOT1—hepatitis B	4.43e-05	0.000232	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2A6—hepatitis B	4.38e-05	0.000229	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.04e-05	0.000211	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GOT2—hepatitis B	3.96e-05	0.000207	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—hepatitis B	3.92e-05	0.000205	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—hepatitis B	3.85e-05	0.000201	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—hepatitis B	3.77e-05	0.000197	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GOT1—hepatitis B	3.42e-05	0.000179	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GGT1—hepatitis B	3.42e-05	0.000179	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—hepatitis B	3.39e-05	0.000177	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—hepatitis B	3.17e-05	0.000166	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—hepatitis B	3.1e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—hepatitis B	3.02e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—hepatitis B	2.99e-05	0.000156	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—hepatitis B	2.9e-05	0.000152	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—hepatitis B	2.84e-05	0.000149	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—hepatitis B	2.78e-05	0.000145	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—hepatitis B	2.58e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—hepatitis B	2.36e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—hepatitis B	2.31e-05	0.000121	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—hepatitis B	2.12e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—hepatitis B	1.82e-05	9.51e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—hepatitis B	1.8e-05	9.4e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—hepatitis B	1.39e-05	7.26e-05	CbGpPWpGaD
